Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in patients with moderate impairment of consciousness after head trauma
IRCT2015052920948N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2015
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 3 trial of cerebrolysin in traumatic brain injury (TBI), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2015; status: completed.
02
Drugs
cerebrolysin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT2015052920948N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015052920948N2.